Showing results (1871-1880 of 2,488) with videos related to

Sort By:
Pageof 249
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95, Russell L Basser, Anne O'Neill, et al.
Nature Genetics|July 2, 2002
Meiotic arrest and aneuploidy in MLH3-deficient miceSteven M Lipkin, Peter B Moens, Victoria Wang, et al.
International Journal of Epidemiology|June 27, 2020
Genetic evidence that higher central adiposity causes gastro-oesophageal reflux disease: a Mendelian randomization studyHarry D Green, Robin N Beaumont, Andrew R Wood, et al.
Frontiers in Aging Neuroscience|January 19, 2024
Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer's disease: a cross-sectional metabolomic analysisXiaobei Pan, Paul C Donaghy, Gemma Roberts, et al.
Genes|September 28, 2023
Integrative Analysis Unveils the Correlation of Aminoacyl-tRNA Biosynthesis Metabolites with the Methylation of the SEPSECS Gene in Huntington's Disease Brain TissueSangeetha Vishweswaraiah, Ali Yilmaz, Nazia Saiyed, et al.
American Journal of Disaster Medicine|February 1, 2017
Effects of humerus intraosseous versus intravenous amiodarone administration in a hypovolemic porcine modelCpt Monica M Holloway, Cpt Shannan L Jurina, Cpt Joshua D Orszag, et al.
BMC Medicine|August 24, 2004
Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse modelPhiline Wangemann, Erin M Itza, Beatrice Albrecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Midlife gene expressions identify modulators of aging through dietary interventionsBing Zhou, Liu Yang, Shoufeng Li, et al.
AIDS and Behavior|November 10, 2025
Randomized Controlled Trial of Game Changers, a Social Network Intervention for HIV Prevention in UgandaLaura M Bogart, Joseph K B Matovu, Harold D Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyM D Green, H Koelbl, J Baselga, et al.
Pageof 249